BiomX Inc. (PHGE) Earnings Call Transcripts
BiomX Inc.'s Latest Earnings Call - April 10, 2026
During the special meeting held on April 10, 2026, BiomX Inc. approved the 2026 Equity Incentive Plan, which includes the issuance of up to 1,390,000 shares of common stock. The approval of this plan is significant as it introduces an evergreen mechanism for share issuance, potentially impacting future equity dilution. However, no financial metrics such as revenue or earnings were discussed in this meeting, and no guidance was provided for the upcoming fiscal year.
Reported metrics
| Metric | Value |
|---|---|
| Shares Approved for Issuance | 1,390,000 (positive) |
| Annual Increase Percentage | 4% (positive) |
| Total Shares Outstanding | 6,543,516 (neutral) |
| Shares Present at Meeting | 3,401,604 (positive) |
Guidance from management
No financial guidance or forecasts were provided during the meeting. The focus was primarily on the approval of the equity incentive plan.
What management said
All having voted who wish to do so, the polls are declared to be closed. Based upon a preliminary count, we have sufficient votes to approve the 2026 plan. On the basis of such report, I hereby declare that the 2026 plan is approved. This completes the business of our agenda. If you have any additional questions for any member of the management, questions may be submitted to the web page. We will respond to appro...
What analysts pressed on
Analysts may be concerned about the potential dilution from the approved equity incentive plan and how it will affect existing shareholders. There was no discussion on financial performance metrics or future earnings guidance, which could raise questions about the company's growth trajectory.
Main topics on the call
- Approval of 2026 Equity Incentive Plan — The 2026 Equity Incentive Plan was approved, allowing for the issuance of up to 1,390,000 shares with an annual increase of 4% based on outstanding shares. This plan is set to commence on January 1, 2027, and will last f...
- Voting Process and Quorum — The meeting confirmed a quorum with 3,401,604 shares present, allowing for the business to proceed. This indicates strong shareholder engagement and support for the company's initiatives.
- Adjournment Proposal — The meeting included a proposal to adjourn if necessary to solicit additional proxies, indicating a proactive approach to ensuring sufficient votes for important decisions.
Read the full BiomX Inc. transcript (April 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About BiomX Inc.
BiomX Inc. (PHGE) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NYSEAM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 22 calls on record spanning August 16, 2021 to June 26, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 22 BiomX Inc. earnings call transcripts on record, spanning August 16, 2021 to June 26, 2026. Based on this history, BiomX Inc. reports quarterly. The most recent call on file is dated June 26, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- PHGE
- Exchange
- NYSEAM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 22
- First call
- August 16, 2021
- Most recent
- June 26, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Shareholder/Analyst Calls | Jun 26, 2026 | Read transcript → |
| Shareholder/Analyst Calls | Apr 10, 2026 | Read transcript → |
| Q3 FY2025 | Nov 12, 2025 | Read transcript → |
| Q2 FY2025 | Aug 13, 2025 | Read transcript → |
| Special Calls | Apr 3, 2025 | Read transcript → |
| Special Calls | Mar 31, 2025 | Read transcript → |
| Q3 FY2024 | Nov 14, 2024 | Read transcript → |
| Q2 FY2024 | Aug 15, 2024 | Read transcript → |
| Q1 FY2024 | May 21, 2024 | Read transcript → |
| Q4 FY2023 | Apr 3, 2024 | Read transcript → |
| Special Calls | Nov 29, 2023 | Read transcript → |
| Q2 FY2023 | Aug 9, 2023 | Read transcript → |
| Q1 FY2023 | May 15, 2023 | Read transcript → |
| Q4 FY2022 | Mar 29, 2023 | Read transcript → |
| Special Calls | Feb 22, 2023 | Read transcript → |
| Q3 FY2022 | Nov 9, 2022 | Read transcript → |
| Q2 FY2022 | Aug 10, 2022 | Read transcript → |
| Special Calls | May 12, 2022 | Read transcript → |
| Q1 FY2022 | May 11, 2022 | Read transcript → |
| Q4 FY2021 | Mar 30, 2022 | Read transcript → |
| Q3 FY2021 | Nov 15, 2021 | Read transcript → |
| Q2 FY2021 | Aug 16, 2021 | Read transcript → |